Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2000
08/08/2000US6100258 Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
08/08/2000US6100254 1-benzyl,3-(p-hydroxybenzyl)-5-(p-hydroxyphenyl),7-chloro-1,4 -benzodiazepin-2-one; administering to treat cancer, and diseases caused abnormal nmda channel regulation
08/08/2000US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases
08/08/2000US6100246 Spiro-piperidine derivatives as inhibitors of nitric oxide synthase
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099863 Spray drying mixture
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000CA2216165C Ndf peptides
08/08/2000CA2188133C Tin-117m-containing radiotherapeutic agents
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2125904C Controlled release formulations coated with aqueous dispersions of ethylcellulose
08/08/2000CA2072575C Anticholinergic agents
08/08/2000CA2056653C Preparation for transdermal drug administration
08/08/2000CA2027041C Aroyl-ureas
08/08/2000CA2012661C Thienylpiperazines, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof
08/08/2000CA2010009C Tricyclic fused pyrimidine derivatives, their production and use
08/05/2000CA2267049A1 Pharmaceutical compositions
08/03/2000WO2000045167A2 Non-invasive method for detecting target rna
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044786A1 Novel potassium channels and genes encoding these potassium channels
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
08/03/2000WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044752A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
08/03/2000WO2000044751A1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044748A1 Process for the preparation of alkyl mercapto methyl ergoline derivatives
08/03/2000WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000WO2000044737A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044725A1 Fused dihydropyridines and use of fused dihydropyridines in the preparation of agents for the treatment of epilepsy
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044408A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
08/03/2000WO2000044376A1 Antidepressant heterocyclic compounds
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044374A1 Use of anticonvulsant derivatives for treating bulimia nervosa
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044361A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
08/03/2000WO2000044353A1 Pharmaceutical compositions
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000030605A3 Method for producing medicaments from plant extracts, in a solid form of administration
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000023587A3 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000WO2000012044A3 Method for the preparation of citalopram
08/03/2000WO2000009675A9 Adenovirus formulations for gene therapy
08/03/2000WO2000009669A9 Human mesencephalon cell lines and methods of use therefor
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006185A3 Methods of using lanreotide, a somatostatin analogue
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000DE19901921A1 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels Polymorphs of telmisartan, to processes for their preparation and their use for the preparation of a medicament
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361516A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
08/03/2000CA2361256A1 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000CA2360997A1 Non-invasive method for detecting target rna
08/03/2000CA2360683A1 Antidepressant heterocyclic compounds
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359317A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2359011A1 Thiazolopyrimidine compound, its production and use
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/02/2000EP1024146A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds
08/02/2000EP1023898A1 Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands
08/02/2000EP1023896A2 Opioid formulations for treating pain
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023322A1 Novel npy family member
08/02/2000EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
08/02/2000EP1023296A1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
1 ... 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 ... 1833